Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.35 |
| ▸ | DUT | P33316 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31421962 | 1.00 | CA12 (0.39) | CA12CA1CA2CA9CA14 | |
| SCHEMBL31421965 | 0.80 | CA12 (0.36) | CA12CA1CA2CA9CA14 | |
| SCHEMBL18246692 | 0.78 | MAPT (0.44) | CA12CA1CA2CA9CA14 | |
| SCHEMBL25619986 | 0.78 | MAPT (0.37) | CA12CA1CA2CA9CA14 | |
| SCHEMBL31421971 | 0.77 | CA12 (0.36) | CA12CA1CA2CA9CA14 | |
| SCHEMBL31421968 | 0.77 | CA12 (0.36) | CA12CA1CA2CA9CA14 | |
| SCHEMBL19556067 | 0.76 | MAPK1 (0.47) | MAPTL3MBTL1RAB9A | |
| SCHEMBL21360006 | 0.75 | L3MBTL1 (0.45) | CA12CA1CA2CA9CA14 | |
| SCHEMBL17892764 | 0.74 | NPSR1 (0.47) | CA1CA2MAPTNPSR1L3MBTL1 | |
| SCHEMBL2804514 | 0.72 | NOTUM (0.41) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085703-A1 | METHODS FOR TREATING P53-ASSOCIATED CANCER | SCORPION THERAPEUTICS, INC. (US) | 2025-04-24 | — | — | WO | disclosed |